2025 Sponsors & Exhibitors

Scimega is a niche Canadian oncology CRO acting in Canada within the context of global cutting-edge oncology trials sponsored by mid-size and smaller biotechs. Skilled in collaborative vendor teaming, Scimega guarantees sponsors the quickest site start-up and highest patient recruitment rate, without sacrificing premium quality data. With an optimal operations design robust enough to address an ever-changing clinical trial landscape, Scimega’s team of Lean Coached oncology experts go above-and-beyond to provide: Local, full-time, permanent hires for exceptional staff quality; An extensive network of Canadian Investigator Sites that frequently emerge among top enrollers, and are activated 50% faster than average for global studies; Optimal site engagement to maximize quality, timely data entry and query resolution; Robust and Lean Scimega methodology and processes are supported by current technology to keep every trial this CRO monitors on the Lean trajectory.

To learn more about the Canadian opportunity or explore an expansion with Scimega, please visit: https://scimega.com/

Worldwide Clinical Trials (Worldwide) is a leading global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications, from discovery to reality. Our full-service clinical development capabilities include bioanalytical laboratory services and Phase I-IV clinical trials, as well as post-approval and real-world evidence studies – all powered by our talented and accessible team of clinicians, scientists, and researchers who bring their first-hand expertise to each clinical program.

At Worldwide, we understand that each customer and project are unique, so we take a collaborative and personalized approach to identify and meet specific needs and goals. Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. We apply this deep therapeutic knowledge to develop flexible plans and quickly solve problems in the rapidly evolving clinical development landscape.

Our team of 3,000+ professionals spans 60+ countries, and believes that through collaboration, and a culture that embraces diversity, equity, inclusion, and belonging (DEI&B), everyone plays an important role in making a world of difference for patients and their caregivers. We are united in cause with our customers to improve the lives of patients through new, innovative therapies.

For more information on Worldwide, visit www.Worldwide.com or connect with us on LinkedIn.

Barrington James are an industry leading, global recruitment business that exclusively serves the Pharmaceutical, Biotechnology and Medical Device sectors. With offices all over the world and hundreds of specialists dedicated to sourcing exceptional talent, we have the capacity and capabilities to deliver world-class recruitment solutions to Life Science companies of all sizes. To learn more, please visit https://barringtonjames.com/

BioPoint is a US-based life sciences consulting organization that brings decades of industry knowledge and expertise to our clients. We offer flexible support whether it is a need for a single resource or our specialized FSP approach, BioPoint can support all facets of drug development. To learn more, please visit https://biopointinc.com/.

Harbor Clinical is a women-owned clinical research services firm. As a Functional Service Provider (FSP) offering Staff Augmentation, Consulting, and Single-Service resourcing models, Harbor Clinical’s mission is based on the goal of forging innovative partnerships, with sponsors and employees, built on a bedrock of communication and transparency. To learn more, please visit https://www.harborclinical.com/

Mesa Science Associates is a veteran-owned small business located within the Frederick Innovative Technology Center Inc. (FITCI) in Frederick, MD. Mesa provides a comprehensive array of pharmaceutical development solutions to the research community including the Federal government. From product development planning to NDA or BLA submission, Mesa’s flexible service model leverages a network of highly skilled research and research support professionals from across the United States. This allows Mesa to effectively consult with laboratory specialists concerning pharmacology, preclinical drug evaluation, clinical studies, CMC development, drug delivery system, and regulatory consulting throughout the drug approval process. To learn more, please visit www.mesascience.com.

Phesi's patient-centric data analytics solutions deliver smarter trials and faster cures. We use our AI-driven Trial Accelerator™ platform with global data from 100 million patients, 195 countries and 4,000 indications to create Digital Patient Profiles and our unique Patient Access Score to assess investigator potential. We deliver actionable insights with unrivalled precision to enable you to optimize protocol design, improve enrollment and reduce patient burden and cycle times. Trial Accelerator has been proven to deliver innovative medicines including Keytruda. We can also help you revolutionize clinical development with Digital Twins and Digital Trial Arms. Learn more at phesi.com